Sign in
4

Changes in Ownership

Dyne Therapeutics, Inc. Filed Acc 0001193125-25-309641

Chief Medical Officer sold 880 shares at $20.72 ($18,234)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Kerr Douglas Chief Medical Officer 2025-12-05 Sale 10b5-1 −880 $20.72 $18,234 87,510 D
Open-market sales · 880 sh · avg $20.72 · $18,234
Loading xslF345X05/ownership.xml…